halometasone and Vitiligo

Topics: Adult; Asian People; Betamethasone; Calcineurin Inhibitors; Combined Modality Therapy; Dermatologic Agents; Female; Humans; Lasers, Excimer; Low-Level Light Therapy; Male; Middle Aged; Skin Pigmentation; Tacrolimus; Vitiligo

We evaluated the efficiency of using a 308-nm excimer laser with either tacrolimus, pimecrolimus, or halometasone for the treatment of childhood vitiligo. Patients who received combined treatments had significantly higher rates of repigmentation in comparison with individuals who underwent excimer laser alone therapy. Moreover, patients who received treatment with excimer laser and halometasone had significantly higher rates of repigmentation, even higher than individuals who were treated with tacrolimus combined or pimecrolimus combined. This regimen was more effective on the face, neck, and limbs. We conclude that the use of a combined excimer laser and halometasone cream has a greater therapeutic effect than laser alone.

Topics: Administration, Topical; Betamethasone; Child; Combined Modality Therapy; Dermatologic Agents; Humans; Lasers, Excimer; Prospective Studies; Skin Pigmentation; Tacrolimus; Treatment Outcome; Vitiligo

Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Epidermis; Female; Humans; Male; Middle Aged; Vitiligo

Topics: Administration, Topical; Adolescent; Adult; Anti-Inflammatory Agents; Betamethasone; Child; Female; Glucocorticoids; Humans; Male; Middle Aged; Ointments; Vitiligo